## Abstract Traditional drug development consists of a sequence of independent trials organized in different phases. Full development typically involves (i) a learning phase II trial and (ii) one or two confirmatory phase III trial(s). For example, in the phase II trials several doses of the new co
✦ LIBER ✦
Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Opportunities and Limitations
✍ Scribed by Christopher Jennison; Bruce W. Turnbull
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 81 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0323-3847
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
This is a discussion of the following two papers in this special issue on adaptive designs: ‘Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: General concepts’ by Frank Bretz, Heinz Schmidli, Franz König, Amy Racine and Willi Maurer, and ‘Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: Applications and practical considerations’ by Heinz Schmidli, Frank Bretz, Amy Racine and Willi Maurer. (© 2006 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim)
📜 SIMILAR VOLUMES
Confirmatory Seamless Phase II/III Clini
✍
Frank Bretz; Heinz Schmidli; Franz König; Amy Racine; Willi Maurer
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 333 KB
Confirmatory Seamless Phase II/III Clini
✍
Heinz Schmidli; Frank Bretz; Amy Racine; Willi Maurer
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 195 KB